StockData
XBiotech Inc. logo

XBiotech Inc. (XBIT) stock

XBITNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 8/30
$1.78−0.07 (-3.78%)

Close on Nov 17, 2026Market cap $54.27MP/E –Yield –

XBiotech market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

XBiotech's market cap was $59.45M on Nov 11, 2026, against $69.21M a year earlier. Over the last 5 years it ranged from $57.32M to $338.33M, with a median of $119.31M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$59.45M-18.4%
2025Dec 31, 2025$72.87M-39.5%
2024Dec 31, 2024$120.39M-1.1%
2023Dec 29, 2023$121.75M+14.0%
2022Dec 30, 2022$106.84M-68.4%
2021Dec 31, 2021$338.33M-26.0%
2020Dec 31, 2020$457.36M-40.3%
2019Dec 31, 2019$766.51M+321.2%
2018Dec 31, 2018$181.96M+30.3%
2017Dec 29, 2017$139.62M-57.5%
2016Dec 30, 2016$328.33M-5.8%
2015Dec 31, 2015$348.42M–

More XBiotech figures

See a number that looks wrong?